Bernd Seizinger R.'s Insider Trades & SAST Disclosures
Bernd Seizinger R.'s most recent trade in Aprea Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Oct. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bernd Seizinger R..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 11 Oct 2024 | 10,000 | 44,730 (0%) | 0% | 2.7 | 26,800 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 34,730 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 7.29 per share. | 13 Mar 2024 | 6,860 | 33,685 (0%) | 0% | 7.3 | 50,009 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche B Warrant | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche A Warrant | |
| Aptose Biosciences Inc | Bernd Seizinger R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 26,825 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 06 Jun 2023 | 6,029 | 26,325 (0%) | 0% | 3.7 | 22,192 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 3.63 per share. | 06 Jun 2023 | 4,068 | 20,296 (0%) | 0% | 3.6 | 14,764 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 324,575 (1%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 18 May 2022 | 50,000 | 318,580 (1%) | 0% | 0.7 | 35,500 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 22,750 | 22,750 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 4,610 | 268,580 (1%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 5,600 | 5,600 | - | - | Stock Option (right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges